PepsiCo India will invest US$ 23.7 million to expand its largest greenfield foods manufacturing plant in Kosi Kalan, Mathura in Uttar Pradesh, which produces the popular Lay’s potato chips .
The infusion would push the company's overall investment in Uttar Pradeshto to about US$ 130 million.
PepsiCo India will set up a new manufacturing line as part of its expansion plan to increase the capacity of the cutting-edge food plant, which will produce one of the world's most popular nacho chip brands, Doritos.
The industry-friendly policies and ease of doing business in the state, according to Ahmed ElSheikh, President of PepsiCo India, allowed them to set up their greenfield food plant in Kosi in less than two years.
When it opens in September 2021, PepsiCo India's plans to supply the food manufacturing facility in Kosi Kalan, Mathura, with about 1,50,000 tons of potatoes annually to produce Lay's, the iconic potato chip brand. Additionally, it is developing a strong backward integration program involving over 5,000 local potato farmers.
The Kosi plant has given thousands of supply chain participants, wholesalers, retailers, etc. a means of support. The plant also promotes diversity, aiming to employ women for at least 30 percent of the positions. It has over 1,500 direct and indirect job openings to offer.
The food plant is also implementing the best sustainability strategies and cutting-edge manufacturing techniques.


SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



